25 May 2013
Keywords: nobilon, vivalis, ebx, licensing, accord, dutch, biopharmaceutical
Article | 04 June 2007
Dutch biopharmaceutical firm Nobilon, which is a unit of Organon, has acquired rights to the EBx embryonic stem cell line ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 June 2007
28 May 2007
24 May 2013
© 2013 thepharmaletter.com